These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 31257224)

  • 1. Integrated multi-omics analysis of genomics, epigenomics, and transcriptomics in ovarian carcinoma.
    Zheng M; Hu Y; Gou R; Wang J; Nie X; Li X; Liu Q; Liu J; Lin B
    Aging (Albany NY); 2019 Jun; 11(12):4198-4215. PubMed ID: 31257224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-omics analysis at epigenomics and transcriptomics levels reveals prognostic subtypes of lung squamous cell carcinoma.
    Xu Y; She Y; Li Y; Li H; Jia Z; Jiang G; Liang L; Duan L
    Biomed Pharmacother; 2020 May; 125():109859. PubMed ID: 32036209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-omics analysis of genomics, epigenomics and transcriptomics for molecular subtypes and core genes for lung adenocarcinoma.
    Zhao Y; Gao Y; Xu X; Zhou J; Wang H
    BMC Cancer; 2021 Mar; 21(1):257. PubMed ID: 33750346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of prognostic markers in sarcomas base on a multi-omics analysis.
    Song Y; Yang K; Sun T; Tang R
    BMC Med Genomics; 2021 Jan; 14(1):31. PubMed ID: 33509178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-omics analysis based on integrated genomics, epigenomics and transcriptomics in pancreatic cancer.
    Kong L; Liu P; Zheng M; Xue B; Liang K; Tan X
    Epigenomics; 2020 Mar; 12(6):507-524. PubMed ID: 32048534
    [No Abstract]   [Full Text] [Related]  

  • 6. Integrative analysis of genomic, epigenomic and transcriptomic data identified molecular subtypes of esophageal carcinoma.
    Ma M; Chen Y; Chong X; Jiang F; Gao J; Shen L; Zhang C
    Aging (Albany NY); 2021 Feb; 13(5):6999-7019. PubMed ID: 33638948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenomic and genomic analysis of transcriptome modulation in skin cutaneous melanoma.
    Chen W; Cheng P; Jiang J; Ren Y; Wu D; Xue D
    Aging (Albany NY); 2020 Jul; 12(13):12703-12725. PubMed ID: 32639949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive data analysis of genomics, epigenomics, and transcriptomics to identify specific biomolecular markers for prostate adenocarcinoma.
    Ye C; Wang H; Li Z; Xia C; Yuan S; Yan R; Yang X; Ma T; Wen X; Yang D
    Transl Androl Urol; 2021 Jul; 10(7):3030-3045. PubMed ID: 34430406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating multi-omics data by learning modality invariant representations for improved prediction of overall survival of cancer.
    Tong L; Wu H; Wang MD
    Methods; 2021 May; 189():74-85. PubMed ID: 32763377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative analysis of genomic and epigenetic regulation of endometrial cancer.
    Zhong Q; Fan J; Chu H; Pang M; Li J; Fan Y; Liu P; Wu C; Qiao J; Li R; Hang J
    Aging (Albany NY); 2020 May; 12(10):9260-9274. PubMed ID: 32412912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification three LncRNA prognostic signature of ovarian cancer based on genome-wide copy number variation.
    Zheng M; Hu Y; Gou R; Nie X; Li X; Liu J; Lin B
    Biomed Pharmacother; 2020 Apr; 124():109810. PubMed ID: 32000042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multi-omics data simulator for complex disease studies and its application to evaluate multi-omics data analysis methods for disease classification.
    Chung RH; Kang CY
    Gigascience; 2019 May; 8(5):. PubMed ID: 31029063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated Analysis of Multiomics Data Identified Molecular Subtypes and Oxidative Stress-Related Prognostic Biomarkers in Glioblastoma Multiforme.
    Ma Y; Xi Z
    Oxid Med Cell Longev; 2022; 2022():9993319. PubMed ID: 36193073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-Omics Integrative Analysis Uncovers Molecular Subtypes and mRNAs as Therapeutic Targets for Liver Cancer.
    Shen Y; Xiong W; Gu Q; Zhang Q; Yue J; Liu C; Wang D
    Front Med (Lausanne); 2021; 8():654635. PubMed ID: 34109194
    [No Abstract]   [Full Text] [Related]  

  • 15. Integrated multi-omics analysis of ovarian cancer using variational autoencoders.
    Hira MT; Razzaque MA; Angione C; Scrivens J; Sawan S; Sarker M
    Sci Rep; 2021 Mar; 11(1):6265. PubMed ID: 33737557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prognostic prediction model for ovarian cancer using a cross-modal view correlation discovery network.
    Wang H; Han X; Ren J; Cheng H; Li H; Li Y; Li X
    Math Biosci Eng; 2024 Jan; 21(1):736-764. PubMed ID: 38303441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Machine learning and multi-omics data reveal driver gene-based molecular subtypes in hepatocellular carcinoma for precision treatment.
    Wang M; Yan X; Dong Y; Li X; Gao B
    PLoS Comput Biol; 2024 May; 20(5):e1012113. PubMed ID: 38728362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Framework for the Integration of Genomics, Epigenomics and Transcriptomics in Complex Diseases.
    Pineda S; Gomez-Rubio P; Picornell A; Bessonov K; Márquez M; Kogevinas M; Real FX; Van Steen K; Malats N
    Hum Hered; 2015; 79(3-4):124-36. PubMed ID: 26201698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated genomic analyses of ovarian carcinoma.
    Cancer Genome Atlas Research Network
    Nature; 2011 Jun; 474(7353):609-15. PubMed ID: 21720365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of ovarian cancer subtype-specific network modules and candidate drivers through an integrative genomics approach.
    Zhang D; Chen P; Zheng CH; Xia J
    Oncotarget; 2016 Jan; 7(4):4298-309. PubMed ID: 26735889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.